| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Co-amoxiclav (mild community-acquired)[1] | Aminopenicillin + beta-lactamase inhibitor | 1.2 g IV pre-op; 1.2 g IV every 8 h × 24–72 h post-op for complicated; switch to oral 625 mg TDS once tolerating diet | 30 mg/kg every 8 h amoxicillin component | First-line peri-operative prophylaxis and empirical for mild community-acquired; review at 48 h with cultures |
| Piperacillin-tazobactam (complicated)[1] | Beta-lactam + beta-lactamase inhibitor | 4.5 g IV every 6–8 h | Per local protocol | Complicated appendicitis (perforated, peritonitis, sepsis); broad gram-positive, gram-negative, anaerobic; renal dose adjustment |
| Ceftriaxone + metronidazole[1] | Third-generation cephalosporin + nitroimidazole | Ceftriaxone 1–2 g IV daily + metronidazole 500 mg IV every 8 h | Ceftriaxone 50–80 mg/kg/day; metronidazole 7.5 mg/kg every 8 h | Alternative for uncomplicated and selected complicated; oral switch when improving |
| Meropenem (severe / ESBL risk)[1] | Carbapenem | 1 g IV every 8 h | 20 mg/kg every 8 h | Reserve for severe sepsis or known ESBL; renal dose adjustment |
Diagnosis with risk-scoring + imaging, antibiotic vs surgical management, and special situations (children, pregnancy, complicated) for acute appendicitis.